HIV Citation List: March 30 - April 12, 2012

Pubmed citations

1. Functional Mechanisms of the Cellular Prion Protein (PrP(C)) Associated anti-HIV-1 Properties. Alais, S., R. Soto-Rifo, V. Balter, H. Gruffat, E. Manet, L. Schaeffer, J.L. Darlix, A. Cimarelli, G. Raposo, T. Ohlmann, and P. Leblanc, Cellular and Molecular Life Sciences, 2012. 69(8): p. 1331-1352; PMID[22076653].
[PubMed]. HIV_0330-041212.

2. HIV-1 Antiretroviral Drug Therapy. Arts, E.J. and D.J. Hazuda, Cold Spring Harbor Perspectives in Medicine, 2012. 2(4): p. a007161; PMID[22474613].
[PubMed]. HIV_0330-041212.

3. Activity of a Novel Combined Antiretroviral Therapy of Gemcitabine and Decitabine in a Mouse Model for HIV-1. Clouser, C.L., C.M. Holtz, M. Mullett, D.L. Crankshaw, J.E. Briggs, M.G. O'Sullivan, S.E. Patterson, and L.M. Mansky, Antimicrobial Agents and Chemotherapy, 2012. 56(4): p. 1942-1948; PMID[22271861].
[PubMed]. HIV_0330-041212.

4. Anti-HIV-1 Activity of Elafin Is More Potent than Its Precursor's, Trappin-2, in Genital Epithelial Cells. Drannik, A.G., K. Nag, X.D. Yao, B.M. Henrick, S. Jain, T.B. Ball, F.A. Plummer, C. Wachihi, J. Kimani, and K.L. Rosenthal, Journal of Virology, 2012. 86(8): p. 4599-4610; PMID[22345469].
[PubMed]. HIV_0330-041212.

5. Microwave-assisted Synthesis of Small Molecules Targeting the Infectious Diseases Tuberculosis, HIV/AIDS, Malaria and Hepatitis C. Gising, J., L.R. Odell, and M. Larhed, Organic & Biomolecular Chemistry, 2012. 10(14): p. 2713-2729; PMID[22227602].
[PubMed]. HIV_0330-041212.

6. Synthesis and anti-HIV Activity of Lupane and Olean-18-ene Derivatives. Absolute Configuration of 19,20-Epoxylupanes by VCD. Gutierrez-Nicolas, F., B. Gordillo-Roman, J.C. Oberti, A. Estevez-Braun, A.G. Ravelo, and P. Joseph-Nathan, Journal of Natural Products, 2012. [Epub ahead of print]; PMID[22462772].
[PubMed]. HIV_0330-041212.

7. Development of a Combination Microbicide Gel Formulation Containing IQP-0528 and Tenofovir for the Prevention of HIV Infection. Ham, A.S., S.R. Ugaonkar, L. Shi, K.W. Buckheit, H. Lakougna, U. Nagaraja, G. Gwozdz, L. Goldman, P.F. Kiser, and R.W. Buckheit, Jr., Journal of Pharmaceutical Sciences, 2012. 101(4): p. 1423-1435; PMID[22227864].
[PubMed]. HIV_0330-041212.

8. Synthesis and Biological Evaluation of 5-Fluoroquinolone-3-carboxylic acids as Potential HIV-1 Integrase Inhibitors. He, Q.Q., X. Zhang, L.M. Yang, Y.T. Zheng, and F. Chen, Journal of Enzyme Inhibition and Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22468749].
[PubMed]. HIV_0330-041212.

9. Short cyclic Peptides Derived from the C-terminal Sequence of Alpha1-Antitrypsin Exhibit Significant anti-HIV-1 activity. Jia, Q., X. Jiang, F. Yu, J. Qiu, X. Kang, L. Cai, L. Li, W. Shi, S. Liu, S. Jiang, and K. Liu, Bioorganic & Medicinal Chemistry Letters, 2012. 22(7): p. 2393-2395; PMID[22406118].
[PubMed]. HIV_0330-041212.

10. A Novel 3,4-Dihydropyrimidin-2(1H)-one: HIV-1 Replication Inhibitors with Improved Metabolic Stability. Kim, J., T. Ok, C. Park, W. So, M. Jo, Y. Kim, M. Seo, D. Lee, S. Jo, Y. Ko, I. Choi, Y. Park, J. Yoon, M.K. Ju, J. Ahn, S.J. Han, T.H. Kim, J. Cechetto, J. Nam, M. Liuzzi, P. Sommer, and Z. No, Bioorganic & Medicinal Chemistry Letters, 2012. 22(7): p. 2522-2526; PMID[22374216].
[PubMed]. HIV_0330-041212.

11. 15-Deoxy-delta(12,14) -prostaglandin J(2) Inhibits Human Immunodeficiency Virus-1 TAT-induced Monocyte Chemoattractant Protein-1/CCL2 Production by Blocking the Extracellular Signal-regulated Kinase-1/2 Signaling Pathway Independently of Peroxisome Proliferator-activated Receptor-gamma and Heme oxygenase-1 in Rat Hippocampal Slices. Kim, S.E., E.O. Lee, J.H. Yang, J.H. Kang, Y.H. Suh, and Y.H. Chong, Journal of Neuroscience Research, 2012. [Epub ahead of print]; PMID[22487967].
[PubMed]. HIV_0330-041212.

12. The Human Immunodeficiency Virus Type 1 Nef and Vpu Proteins Downregulate the Natural Killer Cell-activating Ligand PVR. Matusali, G., M. Potesta, A. Santoni, C. Cerboni, and M. Doria, Journal of Virology, 2012. 86(8): p. 4496-4504; PMID[22301152].
[PubMed]. HIV_0330-041212.

13. Total Synthesis of (-)-13-Oxyingenol and Its Natural Derivative. Ohyoshi, T., S. Funakubo, Y. Miyazawa, K. Niida, I. Hayakawa, and H. Kigoshi, Angewandte Chemie (International ed in English), 2012. [Epub ahead of print]; PMID[22489094].
[PubMed]. HIV_0330-041212.

14. Zinc(ii) Complexes of Constrained Antiviral Macrocycles. Ross, A., J.H. Choi, T.M. Hunter, C. Pannecouque, S.A. Moggach, S. Parsons, E. De Clercq, and P.J. Sadler, Dalton Transactions, 2012. [Epub ahead of print]; PMID[22466936].
[PubMed]. HIV_0330-041212.

15. Molecular Dynamics of HIV1-Integrase in Complex with 93del - A Structural Perspective on the Mechanism of Inhibition. Sgobba, M., O. Olubiyi, S. Ke, and S. Haider, Journal of Biomolecular Structure & Dynamics, 2012. 29(5): p. 863-877; PMID[22292948].
[PubMed]. HIV_0330-041212.

16. Preexposure Prophylaxis with Albumin-conjugated C34 Peptide HIV-1 Fusion Inhibitor in SCID-hu Thy/Liv Mice. Stoddart, C.A., G. Nault, S.A. Galkina, N. Bousquet-Gagnon, D. Bridon, and O. Quraishi, Antimicrobial Agents and Chemotherapy, 2012. 56(4): p. 2162-2165; PMID[22252805].
[PubMed]. HIV_0330-041212.

17. Optimization of 2,4-Diarylanilines as Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors. Sun, L.Q., B. Qin, L. Huang, K. Qian, C.H. Chen, K.H. Lee, and L. Xie, Bioorganic & Medicinal Chemistry Letters, 2012. 22(7): p. 2376-2379; PMID[22406117].
[PubMed]. HIV_0330-041212.

18. Modulation of HIV-1 Gag NC/p1 Cleavage Efficiency Affects Protease Inhibitor Resistance and Viral Replicative Capacity. van Maarseveen, N.M., D. Andersson, M. Lepsik, A. Fun, P.J. Schipper, D. de Jong, C.A. Boucher, and M. Nijhuis, Retrovirology, 2012. 9(1): p. 29; PMID[22462820].
[PubMed]. HIV_0330-041212.

19. Characterization of Pyrimidine Nucleoside Phosphorylase of Mycoplasma hyorhinis: Implications for the Clinical Efficacy of Nucleoside Analogues. Vande Voorde, J., F. Gago, K. Vrancken, S. Liekens, and J. Balzarini, The Biochemical Journal, 2012. [Epub ahead of print]; PMID[22475552].
[PubMed]. HIV_0330-041212.

20. Hydroxyl May not be Indispensable for Raltegravir: Design, Synthesis and SAR Studies of Raltegravir Derivatives as HIV-1 Inhibitors. Wang, Z., M. Wang, X. Yao, Y. Li, W. Qiao, Y. Geng, Y. Liu, and Q. Wang, European Journal of Medicinal Chemistry, 2012. 50: p. 361-369; PMID[22369862].
[PubMed]. HIV_0330-041212.

21. Identification of Small Molecule Inhibitors of the HIV-1 Nucleocapsid - SL3 RNA Complex. Warui, D.M. and A.M. Baranger, Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22480197].
[PubMed]. HIV_0330-041212.

22. Kinase Control Prevents HIV-1 Reactivation in Spite of High Levels of Induced NF-kappaB Activity. Wolschendorf, F., A. Bosque, T. Shishido, A. Duverger, J. Jones, V. Planelles, and O. Kutsch, Journal of Virology, 2012. 86(8): p. 4548-4558; PMID[22345467].
[PubMed]. HIV_0330-041212.

ISI Web of Knowledge citations

23. Synthesis and Biological Activity of Bimorpholine and Its Carbanucleoside. Ausmees, K., A. Selyutina, K. Kutt, K. Lippur, T. Pehk, M. Lopp, E. Zusinaite, A. Merits, and T. Kanger, Nucleosides Nucleotides & Nucleic Acids, 2011. 30(11): p. 897-907; ISI[000298738200007].
[WOS]. HIV_0330-041212.

24. Synthesis of Dialkyl Phosphorylsuccinates from the Reaction of Thiouracil Derivatives with Dialkyl Acetylenedicarboxylates in the Presence of Trialkylphosphites. Azizian, J., K. Yadollahzadeh, H. Tahermansouri, and A.S. Delbari, Phosphorus Sulfur and Silicon and the Related Elements, 2011. 186(9): p. 1844-1852; ISI[000299726800002].
[WOS]. HIV_0330-041212.

25. Synthesis, Characteriztion, and Biological Screening of Some Novel Thizaolidin-4-one and alpha-Aminophosphonate Derivatives. Badadhe, P.V., N.M. Chavan, D.S. Ghotekar, P.G. Mandhane, R.S. Joshi, and C.H. Gill, Phosphorus Sulfur and Silicon and the Related Elements, 2011. 186(10): p. 2021-2032; ISI[000299727300001].
[WOS]. HIV_0330-041212.

26. Liver X Receptor Agonist Inhibits HIV-1 Replication and Prevents HIV-induced Reduction of Plasma HDL in Humanized Mouse Model of HIV Infection. Dubrovsky, L., R. Van Duyne, S. Senina, I. Guendel, T. Pushkarsky, D. Sviridov, F. Kashanchi, and M. Bukrinsky, Biochemical and Biophysical Research Communications, 2012. 419(1): p. 95-98; ISI[000301560500017].
[WOS]. HIV_0330-041212.

27. Discovery of Dimeric Inhibitors by Extension into the Entrance Channel of HIV-1 Reverse Transcriptase. Ekkati, A.R., M. Bollini, R.A. Domaoal, K.A. Spasov, K.S. Anderson, and W.L. Jorgensen, Bioorganic & Medicinal Chemistry Letters, 2012. 22(4): p. 1565-1568; ISI[000300404900015].
[WOS]. HIV_0330-041212.

28. Synthesis of Certain Novel 4H-Pyrano[3,2-h]quinoline Derivatives. El-Agrody, A.M. and A.M. Al-Ghamdi, Arkivoc, 2011: p. 134-146; ISI[000298931900012].
[WOS]. HIV_0330-041212.

29. Pharmacokinetics of Antiretroviral Drugs in Anatomical Sanctuary Sites: The Fetal Compartment (Placenta and Amniotic Fluid). Else, L.J., S. Taylor, D.J. Back, and S.H. Khoo, Antiviral Therapy, 2011. 16(8): p. 1139-1147; ISI[000298719900001].
[WOS]. HIV_0330-041212.

30. Pharmacokinetics of Antiretroviral Drugs in Anatomical Sanctuary Sites: The Male and Female Genital Tract. Else, L.J., S. Taylor, D.J. Back, and S.H. Khoo, Antiviral Therapy, 2011. 16(8): p. 1149-1167; ISI[000298719900002].
[WOS]. HIV_0330-041212.

31. Inhibition of HIV-1 Reverse Transcriptase Associated Activities by the Hydroalcoholic Extract of Casimiroa edulis Seeds. Esposito, F., L. Zinzula, A. Maxia, E. Tramontano, and C. Sanna, Natural Product Research, 2011. 25(11): p. 1067-1073; ISI[000299687100006].
[WOS]. HIV_0330-041212.

32. Enhancing Protein Backbone BindinguA Fruitful Concept for Combating Drug-Resistant HIV. Ghosh, A.K., D.D. Anderson, I.T. Weber, and H. Mitsuya, Angewandte Chemie-International Edition, 2012. 51(8): p. 1778-1802; ISI[000300446100006].
[WOS]. HIV_0330-041212.

33. A Short Hairpin Loop-structured Oligodeoxynucleotide Targeting the Virion-associated RNase H of HIV Inhibits HIV Production in Cell Culture and in huPBL-SCID Mice. Heinrich, J., D. Schols, and K. Moelling, Intervirology, 2012. 55(3): p. 242-246; ISI[000300850700008].
[WOS]. HIV_0330-041212.

34. Multi-scale Modeling of HIV Infection in Vitro and APOBEC3G-based Anti-Retroviral Therapy. Hosseini, I. and F. Mac Gabhann, Plos Computational Biology, 2012. 8(2); ISI[000300729900016].
[WOS]. HIV_0330-041212.

35. The Sugar Ring Conformation of 4 '-Ethynyl-2-fluoro-2 '-deoxyadenosine and Its Recognition by the Polymerase Active Site of HIV Reverse Transcriptase. Kirby, K.A., K. Singh, E. Michailidis, B. Marchand, E.N. Kodama, N. Ashida, H. Mitsuya, M.A. Parniak, and S.G. Sarafianos, Cellular and Molecular Biology, 2011. 57(1): p. 40-46; ISI[000300373200006].
[WOS]. HIV_0330-041212.

36. Schilancitrilactones A-C: Three Unique Nortriterpenoids from Schisandra lancifolia. Luo, X., Y.M. Shi, R.H. Luo, S.H. Luo, X.N. Li, R.R. Wang, S.H. Li, Y.T. Zheng, X. Du, W.L. Xiao, J.X. Pu, and H.D. Sun, Organic Letters, 2012. 14(5): p. 1286-1289; ISI[000300916000026].
[WOS]. HIV_0330-041212.

37. Synthesis, Characterization and Coordination Chemistry of Substituted beta-Amino dicarbonyls. Meskini, I., M. Daoudi, A. Kerbal, B. Bennani, J. Sheikh, A. Parvez, L. Toupet, and T. Ben Hadda, Journal of Saudi Chemical Society, 2012. 16(2): p. 161-173; ISI[000301289200008].
[WOS]. HIV_0330-041212.

38. Synthesis, Antibacterial, and Analgesic Activity of Novel 4-Hydroxy-3-(phenylthio)-2H-chromen-2-ones and 4-Hydroxy-3-[imidazol/tetrazolo-2-yl)thio]-2H-chromen-2-ones. Rajesha, G., K.M. Mahadevan, N.D. Satyanarayan, and H.S.B. Naik, Phosphorus Sulfur and Silicon and the Related Elements, 2011. 186(8): p. 1733-1743; ISI[000299726300014].
[WOS]. HIV_0330-041212.

39. Prediction and in Vitro Evaluation of Selected Protease Inhibitor Antiviral Drugs as Inhibitors of Carboxylesterase 1: A Potential Source of Drug-Drug Interactions. Rhoades, J.A., Y.K. Peterson, H.J. Zhu, D.I. Appel, C.A. Peloquin, and J.S. Markowitz, Pharmaceutical Research, 2012. 29(4): p. 972-982; ISI[000301591100007].
[WOS]. HIV_0330-041212.

40. Synthesis, Structure, and Luminescent Properties of 2-[2-(9-Anthryl)vinyl]quinolines. Serdyuk, O.V., I.V. Evseenko, G.A. Dushenko, Y.V. Revinskii, and I.E. Mikhailov, Russian Journal of Organic Chemistry, 2012. 48(1): p. 78-82; ISI[000301188200011].
[WOS]. HIV_0330-041212.

41. Mitigating hERG Inhibition: Design of Orally Bioavailable CCR5 Antagonists as Potent Inhibitors of R5 HIV-1 Replication. Skerlj, R., G. Bridger, Y. Zhou, E. Bourque, E. McEachern, S. Danthi, J. Langille, C. Harwig, D. Veale, B. Carpenter, T. Ba, M. Bey, I. Baird, T. Wilson, M. Metz, R. MacFarland, R. Mosi, V. Bodart, R. Wong, S. Fricker, D. Huskens, and D. Schols, Acs Medicinal Chemistry Letters, 2012. 3(3): p. 216-221; ISI[000301169400011].
[WOS]. HIV_0330-041212.

42. Quantitative Structure Activity Relationship Studies on a Series of Triazole Derivatives as Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase. Srivastava, A.K., A. Pandey, A. Nath, and V.K. Pathak, Oxidation Communications, 2011. 34(4): p. 843-854; ISI[000300075700011].
[WOS]. HIV_0330-041212.

43. The Cellular Antiviral Protein APOBEC3G Interacts with HIV-1 Reverse Transcriptase and Inhibits Its Function during Viral Replication. Wang, X.X., Z.J. Ao, L.Y. Chen, G. Kobinger, J.Y. Peng, and X.J. Yao, Journal of Virology, 2012. 86(7): p. 3777-3786; ISI[000301371500035].
[WOS]. HIV_0330-041212.

44. Synthesis and Biological Activities of Novel Isoxazoline-linked Pseudodisaccharide Derivatives. Zhang, P.Z., C. Wei, E.K. Wang, W. Wang, M. Liu, Q.M. Yin, H. Chen, K.R. Wang, X.L. Li, and J.C. Zhang, Carbohydrate Research, 2012. 351: p. 7-16; ISI[000301128300001].
[WOS]. HIV_0330-041212.

45. Anti-AIDS Agents 85. Design, Synthesis, and Evaluation of 1R,2R-Dicamphanoyl-3,3-dimethyldihydropyrano-[2,3-c]xanthen-7(1H)-one (DCX) Derivatives as Novel anti-HIV agents. Zhou, T., Q. Shi, C.H. Chen, L. Huang, P. Ho, S.L. Morris-Natschke, and K.H. Lee, European Journal of Medicinal Chemistry, 2012. 47: p. 86-96; ISI[000301169800010].
[WOS]. HIV_0330-041212.

Patent citations

46. Preparation of Pyrimidine Nucleoside Derivatives as Antitumor and Antiviral Agents. Chang, J., H. An, X. Yu, and X. Guo. Patent. 2012. 2011-10245782 102351931: 63pp.
[Patent]. HIV_0330-041212.

47. Serpin-finger Fusions with Biologically Active Polypeptides for Anchoring with High Affinity and Functional Spatial Orientation. Engh, R., E. Kopetzki, and T. Schlothauer. Patent. 2012. 2011-EP65884 2012035034: 37pp.
[Patent]. HIV_0330-041212.

48. Fused Tricyclic ether carbamates for Treating HIV Infected Patients. Ghosh, A.K., C.-X. Xu, H. Mitsuya, and G. Parham. Patent. 2012. 2011-US50393 2012031237: 40pp.
[Patent]. HIV_0330-041212.

49. Compounds and Therapeutic Applications Related to Inhibition of Dendritic Cell Immunoreceptor (DCIR) Activity and Signaling Events. Gilbert, C., A. Lambert, and M.J. Tremblay. Patent. 2012. 2011-CA888 2012021964: 95pp.
[Patent]. HIV_0330-041212.

50. Anti-proliferative Substituted Pyrazolo[3,4-D]pyrimidines to Inhibit Immune Activation, Virus Replication and Tumor Growth. Lori, F., D.D. Forni, and M.R. Stevens. Patent. 2012. 2010-804551 20120022048: 29pp.
[Patent]. HIV_0330-041212.

51. Pyrazolo[1,5-a]pyrimidine Derivatives as Inhibitors of Human Immunodeficiency Virus Replication and Their Preparation and Use for the Treatment of HIV Infection. Pendri, A., G. Li, S. Gerritz, D.R. Langley, G.L. Trainor, and N.A. Meanwell. Patent. 2012. 2011-US50503 2012033735: 250pp.
[Patent]. HIV_0330-041212.

52. Multimeric Inhibitors of Viral Fusion as Antiviral Agents. Pessi, A. Patent. 2012. 2011-EP63888 2012020108: 165pp.
[Patent]. HIV_0330-041212.

53. Daphnane-Type Diterpene Orthoesters Compounds, Their Pharmaceutical Composition, Preparation Method and Application for Preventing or Treating Aids. Zhou, J., Y. Zheng, S. Huang, Y. Zhao, X. Zhang, J. Hu, R. Wang, Y. Liu, and X. Zhang. Patent. 2012. 2011-10234308 102344455: 14pp.
[Patent]. HIV_0330-041212.